ArticlePostepy w kardiologii interwencyjnej = Advances in interventional cardiology2022

Effectiveness and safety of proprotein convertase subtilisin/kexin type 9 inhibitors in patients with familial hypercholesterolemia. Our experience in implementing the drug program of the Polish National Health Fund.

Beata Bobrowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.